Axa
MLAB icon

Axa’s Mesa Laboratories MLAB Stock Holding History

Axa’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,000
Closed -$219K – 1103
2024
Q1 		$219K Hold
2,000
– – ﹤0.01% 1019
2023
Q4 		$210K Hold
2,000
– – ﹤0.01% 1034
2023
Q3 		$210K Hold
2,000
– – ﹤0.01% 1021
2023
Q2 		$257K Sell
2,000
-200
-9% -$30.5K ﹤0.01% 1017
2023
Q1 		$384K Buy
2,200
+400
+22% +$71.7K ﹤0.01% 995
2022
Q4 		$299K Buy
+1,800
New +$282K ﹤0.01% 1049

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Axa's MLAB Position: Q2 2024 in Review

Axa sold out of Mesa Laboratories (MLAB) in Q2 2024, closing a stake of 2,000 shares — an estimated $219K sold.

Axa first reported a position in MLAB in Q4 2022 and held it in 6 quarters. The position peaked at $384K in Q1 2023. 154 funds tracked by Wall St. Rank hold MLAB as of Q2 2024.

  • Axa reported no remaining Mesa Laboratories position as of Q2 2024 after selling out during the quarter.
  • Axa sold 2,000 Mesa Laboratories shares in Q2 2024, an estimated $219K.
  • Axa first reported a position in Mesa Laboratories in Q4 2022 and held it in 6 quarters.
  • Axa's Mesa Laboratories position peaked at $384K in Q1 2023.
  • 154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2024.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.